Dietary camphene attenuates hepatic steatosis and insulin resistance in mice. (10th September 2013)

• Record Type: Journal Article
• Authors: Kim, Sohee; Choi, Youngshim; Choi, Seoyoon; Choi, Yeji; Park, Taesun
• Is Part Of: Obesity. Volume 22:Number 2(2014:Feb.)
• Page Start: 408
• Page End: 417
• Publication Date: 2013-09-10
• Subjects: Obesity -- Periodicals; 616.398005
• DOI: 10.1002/oby.20554
• Languages: English
• ISSNs: 1930-7381

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="oby20554-sec-0001" sec-type="section"> <title>Objective</title> <p>The aim of this study was to investigate the protective effects of camphene on high‐fat diet (HFD)‐induced hepatic steatosis and insulin resistance in mice and to elucidate its mechanism of action.</p> </sec> <sec id="oby20554-sec-0002" sec-type="section"> <title>Design and Methods</title> <p>Male C57BL/6N mice were fed with a normal diet, HFD (20% fat and 1% cholesterol of total diet), or HFD supplemented with 0.2% camphene (CPND) for 10 weeks.</p> </sec> <sec id="oby20554-sec-0003" sec-type="section"> <title>Results</title> <p>Camphene alleviated the HFD‐induced increases in liver weight and hepatic lipid levels in mice. Camphene also increased circulating adiponectin levels. To examine the direct effects of camphene on adiponectin secretion, 3T3‐L1 adipocytes were incubated with camphene. Consistent with <italic>in vivo</italic> result, camphene increased adiponectin expression and secretion in 3T3‐L1 adipocytes. In HFD‐fed mice, camphene increased hepatic adiponectin receptor expression and AMP‐activated protein kinase (AMPK) activation. Concordant with the activation of adiponectin–AMPK signaling, camphene increased hepatic expression of fatty acid oxidation‐related genes and decreased those of lipogenesis‐related genes in HFD‐fed mice. Moreover, camphene increased insulin‐signaling molecules activation and stimulated glucose transporter‐2translocation to the plasma membrane in the liver.</p> </sec> <sec id="oby20554-sec-0004" sec-type="section"> <title>Conclusions</title> <p>These results suggest camphene prevents HFD‐induced hepatic steatosis and insulin resistance in mice; furthermore, these protective effects are mediated via the activation of adiponectin–AMPK signaling.</p> </sec> </abstract>